Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,355 | 13,100 | 10,378 | 2,921 | 429 |
| Receivables | N/A | 300 | N/A | N/A | N/A |
| TOTAL | $1,580 | $13,629 | $11,023 | $3,378 | $855 |
| Non-Current Assets | |||||
| PPE Net | 210 | 313 | 207 | 287 | 88 |
| Other Non-Current Assets | 3,983 | 70 | 48 | 48 | 47 |
| TOTAL | $4,192 | $383 | $255 | $334 | $135 |
| Total Assets | $5,772 | $14,012 | $11,278 | $3,712 | $990 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,837 | 1,055 | 1,196 | 867 | 936 |
| Accrued Expenses | 562 | 1,686 | 206 | 443 | 814 |
| TOTAL | $2,771 | $2,801 | $1,459 | $1,368 | $1,795 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 27 |
| Other Non-Current Liabilities | 8,727 | 3,748 | 2,608 | 1,578 | 2,090 |
| TOTAL | $8,730 | $4,136 | $2,903 | $1,729 | $2,172 |
| Total Liabilities | $11,502 | $6,937 | $4,362 | $3,096 | $3,967 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,857 | 1,419 | 767 | 310 | 265 |
| Common Shares | 49 | 43 | 23 | 9 | 3 |
| Retained earnings | -201,907 | -181,133 | -156,544 | -141,999 | -131,743 |
| Other shareholders' equity | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $-5,729 | $7,075 | $6,917 | $616 | $-2,977 |
| Total Liabilities And Equity | $5,772 | $14,012 | $11,278 | $3,712 | $990 |